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Abstract
High-resolution HLA typing plays a central role in many areas of immunology, such as in identifying immunogenetic risk
factors for disease, in studying how the genomes of pathogens evolve in response to immune selection pressures, and also
in vaccine design, where identification of HLA-restricted epitopes may be used to guide the selection of vaccine
immunogens. Perhaps one of the most immediate applications is in direct medical decisions concerning the matching of
stem cell transplant donors to unrelated recipients. However, high-resolution HLA typing is frequently unavailable due to its
high cost or the inability to re-type historical data. In this paper, we introduce and evaluate a method for statistical, in silico
refinement of ambiguous and/or low-resolution HLA data. Our method, which requires an independent, high-resolution
training data set drawn from the same population as the data to be refined, uses linkage disequilibrium in HLA haplotypes
as well as four-digit allele frequency data to probabilistically refine HLA typings. Central to our approach is the use of
haplotype inference. We introduce new methodology to this area, improving upon the Expectation-Maximization (EM)-
based approaches currently used within the HLA community. Our improvements are achieved by using a parsimonious
parameterization for haplotype distributions and by smoothing the maximum likelihood (ML) solution. These improvements
make it possible to scale the refinement to a larger number of alleles and loci in a more computationally efficient and stable
manner. We also show how to augment our method in order to incorporate ethnicity information (as HLA allele
distributions vary widely according to race/ethnicity as well as geographic area), and demonstrate the potential utility of
this experimentally. A tool based on our approach is freely available for research purposes at http://microsoft.com/science.
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Introduction
The Major Histocompatibility Complex (MHC), located on the
short arm of chromosome 6, encodes the Human Leukocyte
Antigen (HLA) class I and II genes, whose protein products play an
essential role in the adaptive immune response. The HLA class I
and class II proteins bind antigenic, pathogen-derived peptides
(called epitopes) and display them on the cell surface for recognition
by CD8+ or CD4+ T-lymphocytes, respectively, thus activating the
cellular immune response and mediating pathogen clearance.
Critically, each HLA protein can bind only a limited range of
peptides (as dictated by HLA-specific binding motifs), and
individuals express different (and multiple) HLA class I and class
II proteins with different peptide specificities. In addition, the HLA
class I and II genes represent the most polymorphic set of genes in
the human genome; extensive MHC/HLA genetic diversity on
both an individual as well as a population level ensures that the
human immune response will be equipped to target a diverse range
of pathogens. To date, more than 600, 900, and 300 different alleles
have been identified, respectively, for the class I HLA-A,-B and -C-
loci, whereas more than 600 alleles have been identified at the class
II HLA-DRB1 locus; new alleles are routinely being discovered [1].
In addition, due to their location within the MHC region on
chromosome 6, HLA alleles are in tight linkage disequilibrium, and
thus can be thought of in terms of a haplotype [2].
High-resolution HLA typing (meaning the determination of the
specific HLA alleles which an individual expresses at each of the
class I and/or class II loci) is an essential tool for basic as well as
clinical immunology research. For example, HLA typing has been
used to identify immunogenetic risk factors for human diseases
[3,4,5] and more recently has been used to investigate how
pathogens (such as HIV (e.g., [6,7]) and, more recently Hepatitis C
Virus [8,9,10]) evolve in response to HLA-restricted immune
selective pressures. In addition, HLA typing is essential for vaccine
research: the identification and mapping of HLA-restricted T-cell
epitopes in the proteomes of different pathogens (e.g., [11]), could
help inform the selection of potential immunogens in a T-cell
based vaccine design. Clinically, high-resolution HLA typing is
routinely required in the context of modern transplantation
medicine, such as for hematopoietic stem cell transplants: in order
to minimize risk of rejection, donors and unrelated recipients must
be matched with respect to HLA alleles expressed [12].
Historically, HLA typing was performed using low-resolution,
antibody-based serological tests. However, higher-resolution HLA
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based) methods. Molecular methods for HLA typing include
hybridization with sequence-specific oligonucleotide probes
(SSOP), PCR amplification with sequence-specific primers
(PCR-SSP), and more recently, DNA sequence-based methods.
Generally, DNA sequence-based methods involve locus-specific
PCR amplification of exons 2 and 3 (for HLA Class I genes), or
exon 2 only (for HLA class II), followed by ‘‘bulk’’ DNA
sequencing of the amplified product (i.e., sequencing of products
derived from both HLA haplotypes). Sequencing is restricted to
exons 2 and/or 3 because these regions are the major
determinants of HLA peptide-binding specificity and thus contain
enough information to discriminate between most allele combi-
nations. If an individual is heterozygous (i.e., possesses two
different alleles) at any locus, direct sequencing of an amplified
PCR product will yield nucleotide mixtures at positions in which
the two alleles differ in sequence. Consequently, there are two
reasons why modern sequence-based typing methods may yield
ambiguous typing results: first, if the differences between the two
alleles are located outside the genotyped region (in most cases,
exons 2 and/or 3), and secondly, if two or more allele
combinations yield the exact same pattern of heterozygous
nucleotide mixtures when combined into a ‘‘bulk’’ sequence.
Because of the great (and ever-increasing) number of HLA
alleles (and thus growing list of ambiguous combinations),
unambiguous HLA typing is costly, laborious, and limited to
laboratories specializing in this work. For the purposes of scientific
research, HLA types are not always unambiguously determined;
rather, they are only determined up to some ‘‘resolution’’ (i.e.,
level of ambiguity). Additionally, because the number of HLA
alleles is constantly increasing, sequence-based, SSOP and SSP
based typing results, which depend on the list of known alleles,
require constant re-interpretation in light of newly discovered
alleles. This re-interpretation can result in more ambiguity than
originally thought [13]. Perhaps even more importantly, it is often
impossible to re-type historic samples that may have been typed
using lower-resolution approaches.
The practical consequence of these issues is that there is a large
incongruence between the high-resolution HLA typing required
for scientific investigations and the HLA data that is widely
available. As such, any method which can help to increase
resolution of HLA data, post-hoc and at low cost, will provide a
greatly needed service to the scientific and clinical communities. In
this paper, we introduce and evaluate a method for statistical, in
silico refinement of ambiguous HLA types. Our method uses
information available from inferred HLA haplotypes to probabi-
listically refine HLA data. Our method, which relies upon
haplotype inference from unphased data, introduces new meth-
odology to this area which improves upon the most commonly
used approach within the HLA community (i.e., multinomial
parameterization trained with an EM—Expectation-Maximiza-
tion—algorithm).
Our improvements are achieved by using a parsimonious
parameterization, and by smoothing the maximum likelihood
(ML) solution. These improvements make it possible to scale the
refinement to a larger number of alleles and loci in a more
computationally efficient and stable manner. We also show how to
augment our method in order to make use of data arising from
different ethnic backgrounds, and show the potential use of this
experimentally. Our method is evaluated using data from various
sources, and from various ethnicities, as described in the
Experimental section. Additionally, an implementation of our
method is available for community-wide use.
HLA Nomenclature and Typing Ambiguity
HLA nomenclature is closely tied to the levels of possible HLA
ambiguity. Each HLA allele is assigned a letter (or letters) which
designate the locus (e.g., A, B, and C for class I; DRA, DRB1,
DRB2-9, DQA1, DQB1, DPA1, DPB1, for class II.) This letter is
followed by a sequence of numbers, such as A*0301, for one allele
at the A locus. The first two digits describe the allele type; in most
cases the first two digits correspond to the historical serological
antigen groupings. Low resolution HLA typing refers to alleles which
are reported at this two-digit level (e.g., A*03).
The third and fourth digits are used to designate the allele
subtypes, wherein alleles are assigned numbers from 01–99
roughly according to their order of discovery. A minimum of four
digits thus uniquely defines any allele: by definition, any two alleles
which differ in their four-digit number, differ by at least one amino
acid. For example, A*0301 and A*0302 do not encode the same
protein sequence. Because two-digit names are exhausted after 99
alleles, there are a few oddities in the nomenclature. For example,
A*02 and A*92 belong to the same two-digit class as do B*15 and
B*95 [14].) See http://www.anthonynolan.org.uk/HIG/lists/no-
menlist.html and [2] for more nomenclature details. Sometimes
more than four digits are used to designate an allele: the fifth and
sixth digits are used to distinguish alleles which differ only by
synonymous substitutions (i.e., do not change the amino acid
sequence of the protein), while the seventh and eighth digits
distinguish alleles which differ in sequence in the non-coding
regions of the gene (i.e., the introns or the 59 or 39 untranslated
regions). For the purpose of our work, we omit this level of detail
and limit our analysis to the four-digit level only. In any case, there
is not enough data available at the six-to eight- digit resolution
level to do any substantial statistical modeling.
Assuming that HLA resolution beyond four digits are ignored,
there are still various levels of ambiguity that can arise from
molecular (DNA)-based HLA typing methods. For example,
rather than knowing unambiguously which two A alleles a person
has, one may instead know only a list of possibilities; for example,
A*0301-A*3001 or A*0320-A*3001 or A*0326-A*3001. Such
intermediate resolution types may result from sequence-specific PCR
(SSP) based typing where testing with the initial set of PCR
Author Summary
At the core of the human adaptive immune response is the
train-to-kill mechanism in which specialized immune cells
are sensitized to recognize small peptides from foreign
sources (e.g., from HIV or bacteria). Following this
sensitization, these immune cells are then activated to kill
other cells which display this same peptide (and which
contain this same foreign peptide). However, in order for
sensitization and killing to occur, the foreign peptide must
be ‘‘paired up’’ with one of the infected person’s other
specialized immune molecules—an HLA molecule. The
way in which peptides interact with these HLA molecules
defines if and how an immune response will be generated.
There is a huge repertoire of such HLA molecules, with
almost no two people having the same set. Furthermore, a
person’s HLA type can determine their susceptibility to
disease, or the success of a transplant, for example.
However, obtaining high quality HLA data for patients is
often difficult because of the great cost and specialized
laboratories required, or because the data are historical
and cannot be retyped with modern methods. Therefore,
we introduce a statistical model which can make use of
existing high-quality HLA data, to infer higher-quality HLA
data from lower-quality data.
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person might have (which may require further testing with
additional combinations of allele-specific primers and/or cloning
and sequencing of clones before an unambiguous type is achieved).
As previously mentioned, even modern sequence-based methods
may result in ambiguous allele combinations (if sequenced alleles
differ outside the genotyped region, or if different possible allele
combinations result in the same pattern of observed nucleotide
mixtures). Depending on the clinical and/or research purpose of
the HLA typing, additional laboratory testing required for
achieving high-level (i.e., four-digit) resolution are often not
performed for reasons relating to time and cost. In many cases,
intermediate-level resolution data are truncated to two-digit
resolution; in the previous example, this individual would be
reported as having HLA alleles A*03 and A*30.
Although related but different HLA alleles (for example, those
alleles which share the same first two digits) sometimes share
immunogenic properties, higher resolution data allows for more
precise and informative downstream use (e.g., [15]). We are thus
motivated to develop low-cost techniques for improving resolution,
such as the statistical method introduced here.
The input to our statistical HLA refinement method consists of
two data sets. The first is data of interest that have not been typed
unambiguously to a four-digit resolution, but for which we would
like to increase the resolution as much as possible. The second
input is a set of training data consisting of four-digit resolution
HLA types for individual people, where the population is drawn
from one that is the same (or, in practice, as similar as possible) to
the population of interest for which we wish to refine HLA types.
First we train our model on the training data. Then we apply this
trained model to our limited-resolution data of interest. For
example, if a patient in our data set of interest was typed
ambiguously at the A locus as having either (1) A*0243, A*0101,
or (2) A*0243, A*0122, then our statistical model assigns a
probability to each of these two possibilities. More generally, our
model assigns a probability to any number of possibilities (not just
two), and over many loci. To date, we have used our method,
without computational difficulty, to refine up to four loci with 20–
130 alleles at each locus, and, on data sets with up to half a million
possible haplotypes.
To be precise about what kind of HLA typing ambiguities our
approach can tackle, we emphasize that in principle, our approach
can handle any kind of ambiguity, so long as that ambiguity has
been resolved in the training data set, and so long as the ambiguity
can be defined as an allele or set of alleles, taking on some number
of clearly defined possibilities. Two common ambiguities that are
of interest to researchers are i) molecular allele ambiguities, in which
we know that one allele, specified unambiguously (e.g., A*02) is
actually one of several possibilities (i.e., A*0201, A*0202, A*0203,
etc), and ii) genotype ambiguities, in which ambiguity arising when
various combinations of alleles from both chromosomes produce
the same patterns of heterozygous nucleotides in the chromato-
gram). In this paper, we focus our experiments on the first type of
ambiguity, although our approach should work on the second kind
as well. It may also be of interest to predict high-resolution HLA
types from serological data. So long as it is known which
serological types map to which molecular types, our model can, in
principle, tackle these types of data.
Related Work
At the core of our HLA typing refinement model is the ability to
infer and predict haplotype structure of HLA alleles across
multiple loci (from unphased data, since this is the data that is
widely available). If certain alleles tend to be inherited together
because of linkage disequilibrium between them, then clearly this
information can help us to disambiguate HLA types—and far
more so than using only the most common allele at any particular
locus. We derive a method for disambiguating HLA types from
this haplotype model.
Existing methods for haplotype modeling fall into three main
categories: ad hoc methods, such as Clark’s parsimony algorithm
[16] which agglomerates haplotypes starting with those uniquely
defined by homozygous alleles; EM-based maximum likelihood
methods, such as those belonging to the family introduced by
Excoffier and Slatkin, and Hawley and Kidd [17,18], which are
related to the so-called gene-counting method [19]; and full Bayesian
approaches, such as those introduced by Stephens et al. [20], with
more recent advances by others (e.g., [21,22]). Clark’s method is
no longer used, as it is outperformed by other methods. The full
Bayesian methods are more principled than the EM-based
methods because they average over all uncertainty including
uncertainty about the parameters. However, full Bayesian
methods are generally much slower than EM-based methods,
and their convergence is generally more difficult to assess [23],
making them less attractive for widespread use.
The haplotype modeling part of our approach is most closely
related to the EM-based maximum-likelihood methods, although
it differs in several crucial respects. To our knowledge, all
implementations of EM-based maximum likelihood haplotype
models use a full (unconstrained) joint probability distribution over
all haplotypes (i.e., over all possible alleles, at all possible loci) with
the exception of the partition-ligation algorithms noted below.
Furthermore, because they are maximum-likelihood based, they
do not smooth the parameter estimates, thereby allowing for
unstable (i.e., high variance) estimates of rare haplotypes.
Together, these two issues make existing methods difficult to scale
to a large number of loci or to a large number of alleles per locus.
This scalability problem is widely known (e.g., [17,24,25]), and
several attempts to alleviate it have been suggested, such as
eliminating posterior states which can never have non-zero
probability [24], or using a heuristic divide-and-conquer strategy,
called partition-ligation [26,23] in which the joint probability
distribution over haplotypes is factored into independent blocks of
contiguous loci, and the solutions to each block are then
combined. Although these approaches do help alleviate the
problems of scalability, the former does so in a fairly minimal
way, and the latter places heuristic constraints on the nature of the
solution (through use of the blocks). Furthermore, these methods
do not address scaling in the number of alleles, which is the larger
concern for HLA typing. In addition, these methods do not
address the stability of the statistical estimation procedure. Our
EM-based approach tackles the issues of scalability by using a
parsimonious haplotype parameterization. This especially helps
for scaling up to the large number of alleles in HLA data. Our
approach also addresses stability by using MAP (maximum a
posteriori) parameter estimation rather than an ML estimate.
We note that within the HLA community, even recently,
haplotype inference seems to be exclusively performed with the
most basic EM-based algorithm of Excoffier and Slatkin, and
Hawley and Kidd [17,18] (e.g., [27,28,29,30,31,32,33]). In fact, in
one of the most recently available publications, Maiers et al. were
unable to perform haplotype inference for more than three HLA
loci, resorting to more heuristic techniques beyond this number.
With our approach, such limitations are not reached. In addition,
as we shall see, our approach is more accurate.
There are two pieces of work which tackle the allele refinement
problem using haplotype information: that of Gourraud et al. in
the HLA domain [12], and that of Jung et al. in the SNP (single
Statistical Modeling of T Cell Responses
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indirectly tackle the HLA refinement problem, their focus is on
phasing of HLA data in the presence of ambiguous HLA alleles,
and their experimental evaluation is restricted to the phasing task.
Additionally, they use the standard, multinomial, EM-based
haplotype inference approach, which we show to be inferior for
the task of HLA refinement. Also, they do not investigate
population-specific effects as we do here. Jung et al., strictly
speaking, don’t refine their data. Rather, they impute it—that is,
they fill in data that is completely missing. The SNP domain is quite
different from the HLA domain—the problem of SNP haplotype
inferenceoften involves hundredsorthousands of loci,andthereare
usually only two alleles at each locus (and at most four). HLA
haplotype inference, in contrast, involves only a handful of loci with
possibly hundreds of alleles at each locus (because we define a locus
on an HLA level, not a nucleotide level—although one could do
HLA haplotype inference in the nucleotide domain).
Thus, issues of scalability and the specific nature of haplotypic
patternsaresubstantiallydifferentbetweenthesetwo domains.With
respect to methodology, Jung et al. perform imputation in a sub-
optimal way. First, they apply an EM-based haplotype inference
algorithm ([23]) to obtain a single best phasing of their data (i.e., a
ML point estimate). Next, using the statistically phased data, they
compute linkage disequilibrium in the inferred haplotypes using the
standard measure of Lewontin’s linkage disequilibrium. Thus, they
ignore the uncertainty over phases which is available from the EM
algorithm. Also, they choose only the single best imputed value,
ignoring the uncertainty there as well. Our approach incorporates
both types of uncertainty. Lastly, the haplotype inference algorithm
used by Jung et al. does not account for population-specific effects.
Consequently, they do not investigate this area experimentally, as
we do here, showing its potential benefits.
One other study touches on statistical HLA refinement [31]. In
order to estimate haplotype frequencies on serologically-derived
HLA data, Muller et al. modify the standard EM-based haplotype
inference approach to be able to use donors with unsplit serological
HLA types. However, their main purpose is to estimate haplotype
frequencies (at a two-digit serological level) rather than to perform
HLA refinement; and their experiments focus on this former task.
Materials and Methods
Before explaining our model in detail, we first explain the
standard EM-based model and training algorithm used for
haplotype inference [17,18]. Without loss of generality, suppose
that we are performing haplotype inference over three loci, l1, l2,
and l3, with L
i i[f1,2,3g ðÞ alleles at each locus. Then, in the
standard EM-based approach, the probability of a haplotype is
parameterized by a multinomial table which gives the probability
of every possible haplotype,
p(l1,l2,l3)~pl1l2l3: ð1Þ
In this case, there would be L~Pi Li possible haplotypes,
requiring L parameters, pl1l2l3. EM is a general algorithm for
solving ML/MAP parameter estimates in the presence of missing
data/hidden variables [35,36] (which, here, are the phases). In the
present context, EM reduces to iterating between two simple steps:
1. Given the current parameter estimates (for fpl1l2l3g), find the
distribution of phases for each observed genotype. This is the
E-step, where the expectation over haplotypes/hidden states is
computed.
2. Given the distribution over haplotypes/hidden states for each
observed genotype, compute the maximum likelihood param-
eter estimates (in this case, the multinomial parameters). This is
the M-step, where the parameters are maximized with respect
to the expected complete log likelihood, where the expectation is
taken with respect to the posterior over hidden states, and the
complete log likelihood is the likelihood in which the missing
information (the phase) has been probabilistically completed
proportionally to the posterior distribution over phases.
Note that in both of these steps, it is assumed that the
probability of an individual’s genotype data having a particular
phasing is the product of the probability of each of the two
haplotypes defined by the phasing. Thus this approach assumes
Hardy-Weinberg equilibrium (HWE).
As mentioned earlier, there are two main problems with this
modeling approach. The first is that the number of parameters, L,
scales badly with the number of loci and with the number of alleles
at each locus. This creates two practical problems which quickly
come into play —computational limitations on the number of
loci/alleles which can be handled by the algorithm [27], and, poor
stability with respect to the parameter estimation because the
number of parameters tends to be very large relative to the
number of data typically available. We alleviate both of these
problems using several modifications, and show experimentally the
benefits that these modifications provide.
ASoftmax-Based Haplotype Model
First, we describe a model for p(l1,l2,l3,) that uses far fewer
parameters than the full table. Using the chain rule of probability,
we can write
p(l1,l2,l3)~p(l1)p(l2jl1)p(l3j,l1,l2): ð2Þ
Equation 2 does not introduce any conditional independencies. If
we were to use a (conditional) probability table for each of these
three local distributions, then this model would capture exactly the
same information as Equation 1 and would not reduce the number
of parameters. However, instead of using conditional probability
tables, we use softmax regression functions (also known as multilogit
regression) [37,38]. A softmax regression function is an extension of
logistic regression to more than two target classes. Using a softmax
regression function to parameterize p(l3~akjl1,l2), the probability
that the allele at the third locus is the k
th allele, conditioned on the
alleles at the other two loci, l1, l2, we have
p(l3~kjl1,l2)~
exp(wk
1l1zwk
2l2zwk
0)
PL3
j~1 exp(w
j
1l1zw
j
2l2zw
j
0)
, ð3Þ
where wj~(w
j
0,w
j
1,w
j
2) are parameter vectors of the softmax
regression—one for each possible allele, j, at the third locus. Thus,
the softmax regression function takes a linear combination of the
input features, w
j
1l1zw
j
2l2, plus a constant term, w
j
0, to model each
class, which produces a real-valued number for each class. Then,
this real-value is exponentiated, and normalized relative to all of the
other classes, to yield the probability of interest.
Similarly, the softmax regression function for p(l2jl1) in
Equation 2 is written as
p(l2~kjl1)~
exp(vkl1zvk
0)
PL2
j~1 exp(v
j
1l1zv
j
0)
,
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p(l1~k)~
exp(qk
0)
PL1
j~1 exp(q
j
0)
,
with respective parameters, vj~(v
j
0,v
j
1) and q
j
0. Because the alleles
at each locus arediscrete in nature, we use a binarized version of the
inputs. That is, we use a one-hot encoding, wherein each discrete input,
li=k is represented by a binary vector of length L
i that contains all
zeros, except at the k
th position, which contains a one. Correspond-
ingly, the parameter vectors are augmented in length to match this
dimensionality. Thus, in this binary representation, the length of
each w
k would be L
1+L
2+1, and the total number of scalar
parameters required to represent p(l1,l2,l3,) would be
M=L
3(L
1+L
2+1)+L
2(L
1+1)+L
1(1). Note that M grows much more
slowly here as compared to L for the multinomial tables. In
particular, L grows exponentially in the number of loci and alleles,
whereas M grows only linearly. Use of full tables versus the softmax
regression function relates to the well known bias–variance trade-off
[37] which states that the more flexible a model, the more variance
one will have in estimating its parameters. To reduce variance, one
can decrease the flexibility of the model (as we have done by using
softmax regression rather than multinomial parameterizations),
thereby increasing the bias of the learned model (because the family
of possible models is more restricted). Whether one has chosen a
suitable bias-variance trade-off is normally assessed empirically. In
the experimental section, we show that the use of the softmax
regression function improves the accuracy of the HLA refinement
task over use of a multinomial parameterization.
This softmax-based model can be easily extended, by direct
analogy, to more than three loci, and far more efficiently than can
the multinomial-based model. We note that the additive nature of
the softmax regression functions leads to the property that similar
haplotypes have similar joint probabilities. Coalescent priors used
in some Bayesian approaches also have this property, whereas full
tables do not.
Training the Model with EM
We use the EM algorithm to train our model—that is, to choose
good settings of the softmax parameters (w
j, v
j, and q
j) given
observed genotype data. The way in which EM operates for our
model is very similar to the way in which it works for the
multinomial-based models. Again, we iterate between an E-step,
where the posterior over possible phases is computed, followed by
an M-step, where the parameters of the model are computed
based on the posterior computations from the E-step. The
difference, of course, is that the posterior uses our softmax model
to compute the posterior, and our M-step estimates softmax-
regression parameters rather than multinomial parameters.
Formally, let g
d be the observed genotype/HLA data for the d
th
person in our data set. For example, if we have data for three
loci, HLA-A, HLA-B, and HLA-C, then we would have
unphased data for each chromosome, for each locus,
gd~(gd
A1,gd
A2,gd
B1,gd
B2,gd
C1,gd
C2). There are 2
number of loci21 possible
unique phase states, hi
d, that this data can take on (assuming no
ordering of the chromosomes):
hd
1~f(gd
A1,gd
B1,gd
C1),(gd
A2,gd
B2,gd
C2)g
hd
2~f(gd
A1,gd
B2,gd
C1),(gd
A2,gd
B1,gd
C2)g
hd
3~f(gd
A1,gd
B1,gd
C2),(gd
A2,gd
B2,gd
C1)g
hd
4~f(gd
A1,gd
B2,gd
C2),(gd
A2,gd
B1,gd
C1)g:
For the E-step, we compute p(hd
i jgd) for each data point, for each
possible phase. This computation is easily accomplished by
determining the likelihood of the data in each possible phase
state, and then renormalizing these within each person so that P
i p(hd
i jgd)~1. Here, we assume that each phasing is a priori
equiprobable. The likelihood of one datum in a particular phase
state, li
d is given by the product of the likelihood under our
haplotype model, for each of the two chromosomes. For example,
the likelihood for the d
th genotype to be in phase state 2 is given by
ld
2~p(gd
A1,gd
B2,gd
C1)p(gd
A2,gd
B1,gd
C2), ð4Þ
and renormalization of these likelihoods gives us the posterior over
phase states for a single individual,
p(hd
i jgd)~
ld
i P
j ld
j
:
For the M-step, we use the E-step posteriors to compute the
parameter estimates. As mentioned, we use MAP parameter
estimates which are generally more stable. For the prior
distribution of each parameter, we use a zero-centered Gaussian
distribution. The use of this parameter prior is sometimes referred
to as L2 smoothing or L2 regularization, because its use is equivalent to
adding a penalty term to the log likelihood that consists of the
square of the L2 norm of the parameter vectors. Thus, whereas in
a maximum likelihood setting we would, in the M-step, maximize
the quantity
LC~
X
d
X
i
logp(hd
i jgd)ld
i ,
which is the expected complete log likelihood, with respect to the
softmax parameters, w
j, v
j,a n dq
j, we instead maximize the
quantity
LC
L2~LC{l1
XL1
j~1 jjwjjj
2{l2
XL2
j~1 jjvjjj
2{l2
XL3
j~1 jjqjjj
2,
where jjxjj denotes the L2 norm of vector x. This quantity is the
regularized expected complete log likelihood. The regularization
parameters, l=(l1,l2,l3,), which are (inversely) related to the
variance of the Gaussian prior, are set empirically using a hold out
set. Because this MAP estimation problem is embedded inside of an
M-step, the regularization parameters are theoretically not
independent (except for l1 because it does not depend on the
phasing of the data), and hence must be adjusted jointly. We
describe how we do so in the experimental section.
The use of other parameters priors is possible. One commonly
used alternative is the Laplacian prior or, equivalently, L1
regularization. In experiments not reported here, we have found
L2 and L1 regularization to provide comparable performance on
our task.
By iterating between the E-step and the M-step from some
chosen parameter initialization (or, some posterior initialization),
we are guaranteed to locally maximize the log posterior of the
data, L, (keeping the lj fixed),
L(l)~
X
person d
log
X
phase i
ld
i
"#
{l1
X L1
j~1
jjwjjj
2{l2
X L2
j~1
jjvjjj
2{l2
X L3
j~1
jjqjjj
2:
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multinomial table using a Dirichlet prior. This smoothing has the
effect of adding pseudo-counts to the observed counts of the data
when computing the ML estimate during the M-step. In our
experiments, we compare our model against both the traditional
multinomial haplotype model and a Dirichlet regularized
multinomial model.
The ML (and L2-regularized MAP) softmax regression
parameter estimation problem within a single M-step is a convex
problem, and hence not subject to local minima. In contrast, L(l)
is not convex due to unobserved phase and is subject to local
minima. Nonetheless, in our experiments, we did not find local
minima to be a large problem, and leave further discussion of this
to the Experimental section.
As with the traditional algorithm used in the HLA community,
our EM algorithm assumes random mating. In the discussion, we
propose one way to remove this assumption.
Using the Model for Statistical HLA Refinement
As discussed, we first train our model using the EM algorithm
on a data set consisting of four-digit resolution HLA data from a
population similar to that of our data of interest. We then use the
model to probabilistically refine our lower-resolution data set. To
do so, we refine each person’s HLA type independently of the
others. The way we do so, is to exhaustively write out a list of all
possible unique four-digit phasings that are consistent with each
person’s observed genotype data. We do so by first writing out all
possible (mixed resolution) phases, and then expanding each of
these to all possible four-digit phases. For example, if one person’s
observed genotype in the data set of interest was
gd~(A   30,A   3002,B   57,B   0801,Cw   0401,Cw   1502),
then we obtain
hd
1~f(A   30,B   57,Cw   0401),(A   3002,B   0801,Cw   1502)g
hd
2~f(A   30,B   0801,Cw   0401),(A   3002,B   57,Cw   1502)g
hd
3~f(A   30,B   57,Cw   1502),(A   3002,B   0801,Cw   0401)g
hd
4~f(A   30,B   0801,Cw   1502),(A   3002,B   57,Cw   0401)g:
Expanding Equation 5, for example, we then obtain,
hd
1(1)~f(A   3001,B   5701,Cw   0401),(A   3002,B   0801,Cw   1502)g
hd
1(2)~f(A   3002,B   5701,Cw   0401),(A   3002,B   0801,Cw   1502)g
. .
.
hd
1(j)~f(A   3030,B   5701,Cw   0401),(A   3002,B   0801,Cw   1502)g
hd
1(jz1)~f(A   3001,B   5702,Cw   0401),(A   3002,B   0801,Cw   1502)g
. .
.
hd
1(jzk)~f(A   3030,B   5702,Cw   0401),(A   3002,B   0801,Cw   1502)g
. .
.
hd
1(J1)~f(A   3030,B   5713,Cw   0401),(A   3002,B   0801,Cw   1502)g,
Similarly, we expand each of Equations 6–8 to obtain an
additional J
2, J
3, and J
4 possible four-digit phasings. The total
number of possible four-digit phasings consistent with this person’s
observed genotype is thus J=J
1+J
2+J
3+J
4. Alternatively, if our
data set of interest contains genotype-ambiguity (in the form of
possible pairs of alleles), then we expand the data in all possible
ways consistent with those pairs.
If our desired endpoint is a statistical estimate of phased four-
digit data, then we need only compute and renormalize the
likelihood of each member of the list (to get the posterior
probability of each pair of four-digit haplotypes). However, usually
we are interested in a probability distribution over the possible
four-digit genotypes. To obtain this distribution, we sum the
posterior probabilities of those members of the list that are
consistent with each observed genotype. For example,
f(A   3030,B   5713,Cw   0401),(A   3002,B   0801,Cw   1502)g and
f(A   3002,B   5713,Cw   0401),(A   3030,B   0801,Cw   1502)g
would give rise to the same observed genotype: (A*3030, A*3002,
B*5713, B*0801, Cw*0401, Cw*1502), and so their posterior
probabilities would be summed together (along with any other
entries in the list which mapped to the same observed genotype) to
obtain the posterior probability of that genotype.
Leveraged Population Models
Because haplotype patterns are often population (ethnicity)-
specific, a natural approach is to use separate models for each
population, when the populations are known. For example, if the
low-resolution data of interest pertained primarily to individuals
of European descent, then one would train a model using data
from a European population. Or, if the low-resolution data
consisted of both European and Amerindian populations, then one
would train a model on European and Amerindian populations
separately, and then refine the data of interest using the
appropriate model.
Nonetheless, it is likely that some haplotype patterns are
population-specific whereas others are not, or far less so.
Consequently, it would be useful to combine data across
populations, so that as much data as possible is available for
parameter estimation. The challenge of course is how to combine
data when appropriate, to maintain population-specific training
data when appropriate, and to make good choices automatically.
One way to achieve this goal is to augment the feature space
(which so far consists of binary encodings of HLA alleles) with
population features. We can, for example, include a one-hot
encoding of the population labels in our features. Alternatively or
in addition, we can add features that correspond to conjunctions of
the one-hot encodings of allele and population label. Whereas the
first type of augmentation, which we refer to as simple, allows us to
weight the importance of a haplotype by a linear combination of
populations, the second type of augmentation, which we call
conjunctive, allows us to model specific haplotype–population
interactions. In the evaluation section, we shall see that such
leveraged population models can improve performance. Furthermore,
we shall see that the first type of augmentation provides a winning
effect over training populations separately and that adding the
second type of augmentation leads to no additional improvement
in the data set examined.
The idea of leveraging information across multiple populations
is closely related to some of our previous work on epitope
prediction in which we show how to leverage information across
HLA alleles [39], and is an instance of what is sometimes called
multi-task learning [40]. Xing et al. use a hierarchical Bayesian
model to achieve a similar approach when inferring SNP
haplotypes [22].
Why Require an Independent Training Data Set?
One could imagine using a mixed-resolution data set of interest
(which contains some four-digit HLA types) as its own training
data since EM naturally handles incomplete data. If the data that
are missing four-digit resolution information are ignorable, then
such an approach is straightforward [41]. By definition, data that
(8)
(5)
(7)
(6)
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particular datum is missing (in this case, does not have a four-digit
HLA type) is independent of the true, underlying value of the
missing datum (in this case, the four-digit HLA type). Of course, if
the data are not ignorable, then such a procedure can produce
large errors. Unfortunately, missing high-resolution HLA data are
not likely to be ignorable, and hence we require an independent
data set with no missing data.
Statistical Significance
To assess statistical significance of the difference of the
performance of two models (e.g., softmax compared to multino-
mial), either in terms of the number of correct MAP predictions,
or, in terms of the test log likelihood, we used a non-parametric,
permutation-based, paired test, wherein the null hypothesis is that
the average of the pair wise difference in scores is zero.
Suppose the test set contains D individuals, 1,,D, and that each
model, m, assigns a score, sm
d , to each individual (where again, this
score is either the log probability of the correct assignment, or the
number of correct MAP predictions). Then to compare two
models, m1 and m2, we do the following:
N Compute the average difference between paired scores, in
each algorithm,
Dreal~
1
D
P
d (s
m1
d {s
m2
d )
.
N For permutation, k=1,,K (we use K=10,000), permute the
data in a pair wise fashion to obtain data from the null
distribution, and then compute the average difference
between paired scores in this permuted data. That is, for
each permutation, k,
– For each datum, d, swap the value of s
m1
d with s
m2
d with
probability one half. Call the resulting permuted data
vectors, rm1 with rm2, which are the permuted equivalents of
sm1 with sm2.
– Compute the average difference between paired, permuted
scores,
Dk~
1
D
P
d (r
m1
d {r
m2
d )
.
N Then the two-sided p-value for method m1 being statisti-
cally different from m2 is given by the proportion of times
that the average difference observed on permutated data
matched, or exceeded that observed on the real data.
Formally,
p~
1zjjfDkjabs(Dk)§abs(Dreal)gjj
K
,
N where jjxjj denotes the size of the set x, and abs(x) denotes
the absolute value of x. The addition of one to the
numerator smoothes the estimate of p so as to take into
account the number of random permutations performed.
Without this smoothing, one could easily achieve results of
p=0 by using too few random permutations. This induces a
conservative bias (reducing the type I error, and increasing
type II error), which diminishes as the number of
permutations increases.
Data Sets
We used data sets from two main sources, and denote the
number of individuals in each by N. The first data set is a
collection of private data derived from a large collection of disease
cohorts and controls that were all typed in the laboratory of Mary
Carrington. This data set comprises data from four populations,
across three loci, as summarized in Table 1. Note that most of the
African data are derived from African-American individuals, with
a small proportion from outside the United States (N=776). The
Hispanic and European data are solely US-based, while the Asian
data originated in Asia. Because alleles C17, C18 and A74 were
almost never fully resolved to four digits in this data set, we left
these as two digit designations. All but 0.1% of HLA alleles in the
private data set represented common and well-defined alleles (as
classified in [42]). Because these large data sets comprise numerous
smaller data sets (and sub-populations), we tested each data set, at
each locus, for deviance from Hardy-Weinberg Proportions
(HWP) using the conventional MCMC approximation to the
exact test [43]. The number of MCMC samples was chosen to
ensure that the estimated p-value was within 0.01 of the true one
with 99% confidence. Alleles deviating from HWE at a level
p=0.1 or stronger (lower p-values) were: European HLA-C locus
(p=0.003), African HLA-C (p=0.0001), Asian HLA-A, -B, C
(p=0, p=0, p=0.0004). In all of these cases, except for the Asian
HLA-C locus, the deviation was toward homozygosity. EM
algorithms for haplotype frequency estimation have been shown
to be robust against deviations toward homozygosity, with the
explanation that increased homozygosity reduces the amount of
missing phase information that the EM algorithm must overcome
[25]. In any case, our experimental results demonstrate that this
issue is not of such great concern as to invalidate our approach.
Class I genotyping: Genomic DNA was amplified using locus-
specific primers flanking exons 2 and 3. The PCR products were
blotted on nylon membranes and hybridized with a panel of
sequence-specific oligonucleotide (SS0) probes (see http://www.
ihwg.org/protocols/protocol.htm). Alleles were assigned by the
Table 1. Summary of Private Data
ethnicity N # unique A alleles # unique B alleles # unique C alleles
North American European 7526 81 129 48
North American African 3545 60 106 42
Asian 1318 43 76 30
North American Hispanic 881 47 106 35
doi:10.1371/journal.pcbi.1000016.t001
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results were resolved by sequencing analysis. Only exons 2 and 3
were examined during HLA typing. Any subtypes determined by
sequences outside these exons were not distinguished. In these
cases the earliest recognized alleles were assigned, normally the
ones of the smallest digit in their names (e.g., B*5801 instead of
B*5811).
The second data set was taken from the publically available
dbMHC database (http://www.ncbi.nlm.nih.gov/mhc/), which
we used to test our population-augmented model [44,45,46,47,48],
and also for use of our model on four-loci data [49]. These data
are summarized in Table 2.
Results
In order to evaluate our model, and also to compare how it
performs to a multinomial-based model, we use data sets consisting
of four-digit resolution HLA data from individuals. Then we
synthetically mask the known four-digit allele designation for some
loci and some individuals, at random. In this way, ground truth is
available for quantitative assessment. Specifically, we use the
following set-up:
1. Start with a four-digit HLA resolution data set, D.
2. Randomly partition D into 80% for training (Dtrain) and 20%
for testing (Dtest).
3. To learn good settings of the regularization parameters,
randomly partition Dtrain into 80% for a regularization training
set (Strain) and 20% for a regularization hold out set (Shold).
Train a model on Strain, for each value of the regularization
parameters, and then test its performance on Shold. Select the
regularization parameters which perform best.
4. Using the best regularization parameters, train the model on
Dtrain, and then test its performance on Dtest).
To test the performance as mentioned above, we randomly
mask 30% of the four-digit HLA types (on an individual and
independent allele basis) in the test/hold-out set. That is, we
truncate the last two digits of their four-digit designation. We then
use our HLA refinement to obtain a probability distribution for all
four-digit HLA types which are consistent with the masked values.
Then we assess the prediction in two ways. One, we take the four-
digit type with the highest probability as the single, best answer,
and then count how many of these are correct. We refer to this
criterion as the percentage of correct MAP predictions. Two, we compute
the log probability of the correct four-digit resolution HLA type
under our predictive distribution. We refer to this as the test log
likelihood. If we divide this quantity by the number of masked alleles
and then exponentiate, we obtain the geometric mean probability
of the correct four-digit allele under our learned model (which is
more intuitive than the test log likelihood). We refer to this
criterion as the geometric mean probability. The first criterion (%
correct MAP) is intuitive but informal and coarse. It allows us to
easily get a handle on the performance, but throws away valuable
information concerning the probabilities generated by the model
which may be useful in downstream analyses of the data. In our
experiments, we report performance according to both types of
criteria. Note that these values should be compared only within a
given test set.
Although we mask the HLA types at random, this is likely not
the same process that is responsible for the true, observed,
experimental process that results in masking. Nonetheless, we feel
that it is a reasonable proxy, because it focuses on how well
haplotype patterns have been learned, how strong these patterns
are, and how much they can be used to refine HLA data, which is
the question of interest. Additionally, we measure performance
under a 100% masking, and also a locus-by-locus masking, for
broader testing of the performance of our model.
In addition to experimenting with our softmax-based model,
and the multinomial (with and without regularization), we also
compare performance to a baseline model of allele marginals. In
this baseline model, the probability over four-digit HLA types is
proportional to the frequency of that allele in the training set,
regardless of the HLA data at other loci. This model, by
construction, cannot capture haplotype structure. As we shall
see, this model does not perform well.
For the softmax-based model, we first learned the best value for
l1 (i.e., for the first locus) since it is independent of the others.
Then, fixing the value of l1 at its best value, we set all other
li=0.1. For each of the other loci, i, one at a time, we next found
the best value of li conditioned on the fixed values of the other
regularization parameters. We iterated through the loci in this
manner until no changes were made. In our experiments, this
process reached convergence after only two or three cycles
through the loci, indicating that, in practice, the parameters flig
are largely independent of one another. We optimized a single
parameter by searching a grid of possible values. The grid used in
our softmax-based model experiments was 50;10;5;1;0.5;
0.1;0.05;0.01;0.001. For the multinomial-based model, we used
the grid 1;5;10;50;100;500;1000;5000;10,000;50,000 for the
equivalent sample size of the Dirichlet distributions.
Lastly, to determine if there is a statistically significant difference
between our methods (in terms of either test log likelihood, or
number of correct MAP predictions), we use a permutation-based,
Table 2. Summary of dbMHC Data
ethnicity N # unique A alleles # unique B alleles # unique C alleles
# unique DRB1
alleles
Irish 1000 26 49 23 33
North American Asian 393 34 66 24 NA
North American European 287 28 48 21 NA
North American Black 251 28 49 23 NA
North American Hispanic 240 35 62 25 NA
North American Amerindian 229 27 55 22 NA
All except Irish 1400 48 102 31 NA
doi:10.1371/journal.pcbi.1000016.t002
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average of the pair wise difference in scores is zero. Because
10,000 permutations were used, the smallest p-value that could be
obtained was
1
10,000
~1|10{4.
EM Sensitivity to Initialization
Because the objective function we use, the penalized likelihood,
is not convex, our parameter estimation and hence HLA
refinement can be sensitive to the initial parameter setting. (Note
that by parameters, we mean w
j, v
j, and q
j within the multi-logit
functions, and not the regularization parameters, li, nor the
phasings, hi.) To assess the sensitivity of performance to the initial
parameters, we initialized the parameters randomly between 0 and
1 five different times. We performed this assessment on our
Hispanic-labeled private data because this set corresponds to one
of the smaller ethnicity-specific data sets, and because this ethnic
label is less well defined than others. Both factors (small data sets,
and ethnicities that are not well-defined) tend to produce greater
sensitivity to parameter initialization.
When training our softmax-based model, the geometric mean
probability across the five initializations was aways 0.5255. (A larger
geometric mean probability is better.) In all five runs, 262 of the 306
masked alleles werecorrectly predicted, indicatinglittle sensitivity to
parameter initialization. Similarly, for the regularized multinomial-
based model, the geometric mean probabilities across the five
initializations was always 0.4180. In all five runs, 262 of the 306
masked alleles were correctly predicted, again indicating little
sensitivity. For the unregularized multinomial-based model, the
geometric mean probabilities across the five initializations were:
0.0077, 0.0117, 0.0126, 0.0092, and 0.0105. Of the 306 masked
alleles, 260, 265, 260, 266, and 262 were correctly predicted across
the five runs, indicating a far greater sensitivity to initial parameters.
The geometric mean probability was best for the softmax-based
model, followed by the regularized multinomial, followed by the
unregularized multinomial model (which does poorly due to its
inability to make stable estimates for the huge number of
parameters it requires). This is a pattern we shall see throughout
our experiments.
The sensitivity we see here will allow us to gauge how important
observed differences are in the remainder of the experiments,
where we always initialize the parameters to be all zero. Of course,
when deploying this method in a real setting, it would be wise to
try several parameter initializations, and then to choose the one
that yields the highest likelihoods on hold-out data. Also note that,
for the unregularized multinomial model, we regularize it with an
equivalent sample size of 1610
216 so that negative infinities do not
appear when haplotypes not seen in the training sample appear in
the test set.
Large Scale Data Set Comparison
Next we used our large, private data set to measure the
refinement performance of the various models we have discussed.
We trained and tested within each ethnic population separately.
The results are summarized in Figure 1.
The softmax model has the best performance overall and can
correctly resolve a substantial number of ambiguous alleles. In
terms of both criteria, the softmax model is significantly better
than the other methods (see Table 3 for p-values). The allele
marginal model consistently has the worst performance in terms of
number of correct MAP predictions, presumably because it does
not make use of linkage disequilibrium. In contrast, it significantly
outperforms the unregularized multinomial model in test log
likelihood (p=1 610
24), because the allele marginals are naturally
regularized due to the small number of parameters.
When Training and Test Set Are Not Identically
Distributed
In realistic settings where our algorithm will be deployed, it is
likely that the data set of interest is not drawn from exactly the
same distribution as the training data. To get a sense of how robust
our approach is to deviations from this idealized setting, we have
European African Asian Hispanic
0
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1
Geometric Mean Probability of Correct Answer
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Figure 1. Results on private data, separately for each ethnicity.
Each set of grouped bars represents the four different modeling
approaches. From darkest to lightest: softmax, regularized multinomial,
unregularized multinomial, allele marginal. The number of masked
alleles, respectively, in the European, African, Asian, and Hispanic data
sets was 2669, 1287, 477, and 306, respectively.
doi:10.1371/journal.pcbi.1000016.g001
Table 3. Statistical Significance Results on Private Data, Separately for Each Ethnicity.
Method 1 Method 2 log likelihood p-value # correct MAP p-value
softmax* regularized mult. p=10
24 p=2.8 610
23
softmax* non-reg. mult. p=10
24 p=8 610
24
softmax* allele marginals p=10
24 p=10
24
regularized mult.* non-reg. mult. p=10
24 p=0.51
non-reg. mult.* allele marginals* p=10
24 p=10
24
*Denotes the method that performed better (except for the last row, where the allele marginals perform better than the unregularized multinomial on thel o g
likelihood, but worse on the number of correct MAP predictions.
doi:10.1371/journal.pcbi.1000016.t003
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setting. In particular, we evaluated our refinement accuracy when
the training and test distributions were drawn from different
populations.
First, we split the dbMHC Irish data set (HLA-A, HLA-B,
HLA-C alleles) into 80% training data and 20% test and masked
30% of the test alleles to two digits. Then we trained a model using
the training data, and tested on the test data. Next, we used the
model we had previously trained on the ‘private North American
European’ data, and used this model to predict the same masked,
Irish alleles. Of the 200 people in the Irish test set, there was one
person who contained one allele never observed in the European
data (B*2409, which is actually a null allele, B*2409N, for which
the typing of the private data was not capable of finding). After
removal of this person, we then compared the performance when
using the dbMHC Irish data set itself for traning, as compared to
using our much broader private European data set for training.
The resulting test geometric mean probabilities of the test set were
0.8851 when training with the dbMHC Irish, and 0.8891 with the
private European. This difference was not significant (p=0.44).
Next, we used the model trained on the private Asian data to
predict a 30% masking of 279 dbMHC Canton Chinese
individuals [50] with HLA-A,-B, -C data (we randomly chose this
population among the Asian dbMHC populations available). Nine
of these individuals had alleles not appearing in the training data
(A*0210, B*1505, B*1803, B*3508, B*3520, B*4010, B*5801,
B*7802), and after their removal, we achieved a prediction
accuracy of 441/487=91%, roughly equal to the 90% achieved
when testing on the private
Asian data set itself. Because this dbMHC data set was not large
enough to partition into a training and test set, we were not able to
measure accuracy achieved when training on itself. This is true for
the next three dbMHC data sets as well, in which we perform
similar experimentation.
Next we used a model trained on the private North American
African data set, to predict masked alleles in 251 dbMHC African
American individuals, of which five individuals contained alleles
not matching the training data (A*6804, B*1502, B*1515,
B*5802). After removal of these individuals, 321/373=86% of
masked alleles were correctly predicted, which is lower than the
90% accuracy achieved when testing on the private North
American African data itself. Results were comparable when we
first removed individuals from Africa from the training data
(leaving only US-based individuals of Africans descent).
Next, we used a model trained on the private North American
European data set (containig 776 individuals), to predict masked
alleles in 287 dbMHC North American European individuals, of
which three individuals contained alleles not matching the training
data (B*1802, B*4408, B*5202). After removal of these individuals,
478/510=94% of masked alleles were correctly predicted,
roughly equal to the 95% accuracy achieved when testing on
the private North American European data set itself.
Finally, we used a model trained on the private North American
Hispanic data set, to predict masked alleles in 240 dbMHC North
American Hispanic individuals, of which 13 individuals contained
alleles not matching the training data (A*0212, A*0213, A*2422,
A*2608, A*3401, A*6805, B*5105, B*3509, B*4406). After
removal of these individuals, 344/400=86% of masked alleles
were correctly predicted, comparable to accuracy achieved when
testing on the private North American Hispanic data set itself.
Based on this small set of experiments, we believe it may often
be feasible to use our broadly defined ethnic categories for
resolving ambiguity in other, independently created data sets
falling in to the same broad category, or falling into a much more
specific sub-category. Of course, this may not generally be true,
and in particular, it may be less true for African-derived data.
Additionally, a user of a trained model might have access to some
high-resolution data for their population of interest, and could thus
see how well the trained model works for the subset of their data
(by synthetically masking it) before using the model to resolve
ambiguity in their low-resolution data.
Note that there are two statistical desiderata when using our
method: 1) to use a training data set which mostly closely mimicks
the HLA haplotype distribution of the data set of interest, and 2) to
get as many training data as possible. Critically, these two
desiderata are frequently odds with one another. That is, often a
data set of interest is sub-population specific and therefore difficult
to obtain high resolution data for in large quanitities. However, by
loosening the strictness of the match between training and test
populatations, one can often significantly increase the amount of
data available. Without more data and experimentation, it is
diffult to assess the optimal trade-off between these desiderata.
However, as we see, using broad, even presumably admixed
training data, can lead to useful results.
Sensitivity to Training Data Set Size
To determine whether the availability of more training data
may lead to improved refinements, we examined the sensitivity of
performance to the size of the training set. For the European and
the African private data sets, we iteratively halved the sample size
of training data, where the largest available training data set sizes
were, respectively, 6020 and 2836. The results shown in Figure 2
suggest that more training data would improve the performance
on the African data set, and to a smaller extent, on the European
data set. Note that the African data set is smaller to start with than
the European one, and also known to be more genetically diverse;
both are explanations for the observed trends.
Leveraged Population Models
To determine whether leveraging information across popula-
tions is useful, we compared our leveraged population models to
those built separately on each population. We did so on data from
dbMHC, which contains a diverse set of populations. (We
excluded the Irish population because this population is extremely
homogeneous relative to the others.) Recall that we introduced
two types of leveraging features: simple and conjunctive. We used
our softmax model both with the simple features alone, and with
both the simple and the conjunctive features, as shown in Figure 3.
The performance of the population-augmented models are
significantly better than the softmax model on test log likelihood
(e.g., p=0.02 when comparing softmax+simple to softmax).
Although ethnicity labels are notoriously unreliable, they clearly
provide beneficial information here. Also, the addition of
conjunctive features lends to no apparent improvement.
Sensitivity to Variable Ordering
Because we use softmax regression functions in our haplotype
model, the order in which we apply the chain rule (Equation 2) to
our loci will have an effect on predictive accuracy. We examined
the sensitivity of performance to variable ordering on three loci
(A,B,C) using the European and Hispanic data sets. The results are
shown in Figure 4 in which a locus order of ‘B A C’ means we used
p(A,B,C)~p(B)p(AjB)p(CjA,B). The experiments labeled ‘30%
mask’ denote the performance using the 30% random masking
procedure we used in our earlier experiments. Additionally, we
systematically masked all (and only) A alleles (‘A mask’), and
separately, all and only B alleles (‘B mask’), and all and only C
alleles (‘C mask’). This procedure allows us to see if the variable
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Statistical significance was measured only on the difference in test
log likelihoods.
For the ‘30% mask’ experiments, no statistically significant
(p(0.01) differences were found between variable orderings (and
hence the results of our previous experiments should not have
been effected by this issue). For the locus-specific maskings in the
European data set, only the B alleles showed significant differences
(order 1 vs. 4, p=0.0002; 1 vs. 6, p=0.001; 2 vs. 4, p=0.003; 2
vs. 6, p=0.004; 3 vs. 4, p=0.0006; 4 vs. 5, p=0.006). For the
locus-specific maskings in the Hispanic data set, the A alleles
showed some significant differences (order 1 vs. 2, p=0.004; 1 vs.
5, p=0.001; 3 vs. 5, p=0.004), the B alleles did not show any, and
the C alleles showed one (order 4 vs. 5, p=0.003).
Note that it is possible to use a parsimonious model which is not
dependent upon variable ordering (a so-called ‘undirected’ model
[51] in the parlance of the graphical models community). In
particular, one can form pair-wise ‘compatibility’ functions
between all pairs of HLA loci so that
p(l1,l2,l3)~
Wl1,l2Wl2,l3Wl3,l1 P
i
P
j
P
k Wli,ljWlj,lkWlk,li
,
where the Wli,lj are scalar parameters of the model and where the
sum in the denominator is a normalizing constant and sums over
all possible haplotypes, (li,lj,lk,). However, brief experimentation of
this model applied to the current problem did not indicate
increased performance relative to our softmax-based model.
Locus-Specific Predictive Accuracy
In some domains, the ability to predict certain loci is of greater
importance than others. For example, in HIV research, the ability
to predict B alleles is often paramount (e.g., [15]). We measured
locus-specific prediction accuracy for each locus by applying locus-
by-locus maskingto allfour populations in the privatedata. Figure 5
shows the results, which do not indicate any particular pattern.
Note that the number of possible alleles at each locus has a direct
effect on ourability to predict (as does the linkage between one locus
and the others), and so we might expect, a priori, for the B alleles to
be more difficult to predict, although this does not appear to be the
case.
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Figure 2. Sensitivity to training data set size for the European and African data sets. Top row shows the geometric mean probabilities; the
bottom row shows the percentage of correct MAP predictions.
doi:10.1371/journal.pcbi.1000016.g002
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Figure 3. Results for population-augmented model. Abbrevia-
tions are: SSC=softmax+simple+conjunctive, SS=softmax+simple,
S=simple, RM=regularized multinomial, M=non-regularized multino-
mial, AM=allele marginals, S=separate. The number of masked alleles
in the test set was 514. For all methods, except ‘separate’, a single
model was trained on data from all ethnicities.
doi:10.1371/journal.pcbi.1000016.g003
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PLoS Computational Biology | www.ploscompbiol.org 11 2008 | Volume 4 | Issue 2 | e1000016Figure 4. Sensitivity to Variable Ordering. Top two rows are for the Hispanic data set; bottom two rows are for the European data set. Within
each of these, the top row is the geometric mean probabilities, and the bottom row shows the percent correct MAP predictions. The number of
masked alleles, respectively, in the Hispanic 30% and loci masks (A,B,C), was 306 and 354. The number of masked alleles, respectively, in the European
30% and loci masks (A,B,C), was 2669 and 3012.
doi:10.1371/journal.pcbi.1000016.g004
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Finally, in some instances, only low-resolution data (i.e., two-digit
resolution) is available. Consequently, we investigated the prediction
accuracy of our algorithm in this situation—that is, when 100% of
the alleles were masked to two-digit. The results for the private
African, Asian, and Hispanic data sets are shown in Figure 6.
Because of the large number of allele combinations in the European
data set, it was not possible to perform this experiment in a
reasonable amount of time using the current sequential implemen-
tation of the algorithm. This problem should not be a big concern,
however, as the algorithm can be easily parallelized.
In order to gauge how much haplotype information is being
used in this context, we compare the results to those from the allele
marginal model. In all cases, the softmax model performs
significantly better than the allele marginal model (p=1 610
24
for all three population comparisons on the test log likelihood).
Thus, a large amount of haplotype information is being used by
our model in this 100% masking context, and prediction of four-
digits from strictly two-digit data is feasible. For comparison,
Figure 6 includes the results presented earlier from the 30%
masking experiments. To make the test log likelihoods compara-
ble, we have normalized them by the number of alleles in the test
set. Interestingly, the performance is comparable across the
different maskings according to both criteria.
Four-Loci Example/Class I and Class II
We compared our methods on data with four loci, spanning the
HLA-A, -B, -C and -DRB1 loci. The four-loci data available to us,
with the largest sample size, was the Irish set in dbMHC. As shown
in Figure 7, we see that the relative performance of the methods is
roughly the same as in earlier experiments. Given that LD may
not be as strong between class I and class II alleles, it is of interest
to determine how well each locus can be predicted. Thus we used
a locus-specific masking, as described earlier. The accuracy at each
of the HLA-A, -B, -C and -DRB1 alleles was respectively 97%,
98%,99%, and 80%. This indicates that there is not sufficient
linkage between the HLA-A, -B, -C loci and the HLA -DRB1
locus to accurately resolve ambiguity at the DRB1 locus. However,
it may be the case that with additional class II loci, refinement of
class II data would be feasible.
Discussion
We have introduced a method for statistical refinement of low or
intermediate resolution HLA data, when a full resolution training
data set from a similar population is available. In doing so, we have
alsoimprovedupontheEM-basedapproachtohaplotypeestimation
by using a more parsimonious parameterization of the haplotype
distribution. Experimentally, we show both that it is feasible to use
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75
85
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Percent Correct MAP Predictions
Figure 5. Locus-Specific Predictive Accuracy. Each set of grouped
bars, from darkest to lightest, represents, respectively, A-masking, B-
masking, and C-masking. The number of masked alleles in each
masking was 3012, 1418, 528, and 354, respectively, for the European,
African, Asian, and Hispanic test sets.
doi:10.1371/journal.pcbi.1000016.g005
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Figure 6. Low Resolution Prediction. Each set of grouped bars
represents, from darkest to lightest, respectively, 100% mask with
softmax model, 100% mask with allele marginals model, 30% mask with
softmax model, 30% mask with allele marginals model. The number of
masked alleles for the 100% mask was 4254, 1429, and 1062, and for the
30% mask, 1287, 477, and 306, in the African, Asian, and Hispanic test
sets, respectively.
doi:10.1371/journal.pcbi.1000016.g006
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Figure 7. Four-loci, dbMHC Irish data. Abbreviations are: S=soft-
max, RM=regularized multinomial, M=non-regularized multinomial,
AM=allele marginals. A total of 468 alleles were masked in the test set.
doi:10.1371/journal.pcbi.1000016.g007
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outperforms the standard multinomial-based models used through-
out the HLA community for haplotype estimation. Our HLA
refinement method helps to mitigate the limiting factor of cost in
HLA typing today, and allows for lower/intermediate resolution, or
historical data to be statistically refined when it cannot be refined by
assay. A tool based on our approach is available for research
purposes at http://microsoft.com/science.
Although there is widespread caution about the use of assigned, or
self-defined ethnicity labels [52], we show that the labels associated
with dbMHC data carry useful information. Furthermore, we show
that by augmenting our softmax-based HLA model, we can make
use of these labels to increase the amount of data available while
automatically using it in a population-appropriate manner. Future
workof interestwouldbeto model the datainyet anotherway:using
a mixture of haplotype models, in which each component of the mixture
represents one well-defined population (either as defined in the
training data, or as uncovered in an unsupervised manner). Then,
when data contain multiple populations without ethnicity labels or
when labeled populations contain mixtures of latent (unknown)
subpopulations, one can use these mixture models to uncover
population structure and appropriate weightings of the different
populations for individuals in a data set of interest.
Because our modeling approach assumes that the training and
testing populations are drawn from the same distribution, one
should take care when trying to use this approach for case-control
studies where case and controls are thought to be drawn from
different distributions. One may also be wary of using this
approach in the domain of transplantation, for similar reasons
(patients requiring transplants likely make up a specific sub-
population). However, since HLA ambiguity resolution is applied
in the area of transplants to potential donors in a registry, rather
than the patients themselves (who are routinely typed at high
resolution), application in this domain should not be problematic.
As with the traditional algorithm used in the HLA community,
our EM algorithm assumes HWE. One could make a small change
to our model which would allow us to circumvent making such an
assumption. In the models discussed so far, the probability of data
in a particular phasing is defined as follows. If a haplotype, h,i s
specified by partitioning the genoytpes, gA1,gB1,gC1,gA2,gB2,gC2 into
two sets: f(gA1,gB1,gC1),(gA2,gB2,gC2)g, then the probability of the
data given this phasing is defined as the product of the probability
of each haplotype:
p(hjf(gA1,gB1,gC1),(gA2,gB2,gC2)g)~
p(gA1,gB1,gC1)p(gA2,gB2,gC2)
ð9Þ
where each of the probabilities p(gA1,gB1,gC1)a n dp(gA2,gB2,gC2)a r e
specified by a haplotype model (e.g., softmax or multinomial). To cir-
cumvent the assumption of HWE, one could instead define a model
which does not factor this probability into two independent terms:
p(hjf(gA1,gB1,gC1),(gA2,gB2,gC2)g)~
p(gA1,gB1,gC1,gA2,gB2,gC2),
ð10Þ
wherenow wewouldnot haveahaplotype-basedmodel,butinstead
a more generic, ordered-genotype model, which could itself be given a
softmax-based parsimonious parameterization. The downside of
suchanapproachisthatweessentiallyhalvetheamountofavailable
data, because we no longer have two independent data samples
from each individual, and hence far more data would be required to
effectively make use of such a model.
Future work in probabilistic HLA refinement may involve
comparing EM-based approaches to full Bayesian approaches.
Also, an interesting, though perhaps computationally difficult
avenue to pursue would be the use of HLA DNA sequences to
better model rare haplotypes, or the use of SNP data to directly
predict HLA types.
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